2014 Annual Meeting of the American Urological Association: early screening and molecular markers of prostate cancer.
- Author:
Tao TAO
;
Han GUAN
;
Ming CHEN
- MeSH:
Biomarkers, Tumor;
blood;
Early Detection of Cancer;
Florida;
Humans;
Male;
Prostatic Neoplasms;
blood;
diagnosis;
therapy;
Risk Factors;
Societies, Medical;
Testosterone;
blood;
United States;
Urology
- From:
National Journal of Andrology
2015;21(6):555-560
- CountryChina
- Language:Chinese
-
Abstract:
The 109th Annual Meeting of the American Urological Association was held in Orlando, Florida, USA in May 2014, which received more than 1,000 abstracts on prostate cancer (PCa), covering new epidemiological data about PCa, new theories of early screening, novel molecular markers, new surgical methods, new ideas of diagnosis and treatment of castration-resistant PCa, and progress in basic researches. This paper focuses on the new theories of early screening and novel molecular markers of PCa, including the risk factors of PCa, a revolutionary understanding of the relationship between testosterone and PCa, and new application of PSA, new imaging techniques and molecular markers in the early diagnosis of PCa.
